Precigen, Inc. (PGEN) is a biotechnology company focused on the development and commercialization of advanced therapeutic and diagnostic technologies. The company specializes in genome engineering and genetic manipulation, enabling the development of novel drugs and diagnostic tools for the treatment and detection of various diseases. Their technologies include CRISPR-Cas9 and other genome editing tools, gene therapy, immunotherapy, and genetic analysis-based diagnostic tests.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
